Left bundle area pacing with Closed Loop Stimulation in dual‑chamber pacemakers
Official title: Observation of Clinical Routine Care for Patients Implanted With BIOTRONIK Devices Used for Conduction System Pacing (CSP) With Focus on Closed Loop Stimulation (CLS)
Run by Biotronik SE & Co. KG · NCT07608822 · Data updated 2026-11-12
This study tests whether a dual‑chamber pacemaker using left bundle area pacing and Closed Loop Stimulation can reduce device‑detected atrial fibrillation over 24 months in patients with sinus node disease and AV conduction issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 18 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Biotronik SE & Co. KG Industry-sponsored |
| Locations | 12 sites (Ústí nad Labem and 11 other locations) |
| Status | Recruiting |
| Started | May 29, 2026 |
| Main results expected | May 29, 2028 |
| Study ends | May 29, 2030 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07608822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Patients with sinus node dysfunction and concomitant AV conduction disorders, indicated for standard dual‑chamber pacing with DDD‑CLS mode activated.
✕Probably not a fit
Patients without device‑detected AF or without improvement in rhythm management may not experience a benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, observational submodule of the BIO|STREAM.CSP registry. It collects real‑world data on BIOTRONIK dual‑chamber pacemakers that use left bundle area pacing in combination with Closed Loop Stimulation. The study looks at the incidence of device‑detected atrial fibrillation over 24 months and how CLS adjusts pacing rates when the ventricular lead sits in the conduction system. It also aims to characterize the physiological pacing behavior and safety in routine clinical practice. Eligible patients have sinus node disease with AV conduction disorders and meet standard dual‑chamber pacing indications.
Why it matters
Potential benefit: If successful, the approach could reduce atrial fibrillation burden and improve rhythm management for patients needing dual‑chamber pacing.
How similar studies have gone: Other CSP and CLS studies have shown promise for more physiological pacing, but the specific LBBAP+CLS combination in a real‑world registry is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Enrolled in the BIO\|STREAM.CSP registry * Standard indication for dual-chamber pacing due to any form of sinus node disease according to guidelines * DDD-CLS pacing mode activated * Either ≥ II degree AV block, or native PR interval ≥ 200 ms at baseline ECG with expected RVP ≥ 20% Exclusion Criteria: * Implantation dates back more than 90 days * History of clinical AF * Patients intended to receive, or already received a pacing lead for traditional RV pacing, His bundle pacing or right bundle branch pacing * Upgrade from previous pacemaker system * Patients transitioning from the BIO\|MASTER.CSP study * DDAF episodes present in the device memory at the time of registration
Where it's running
-
A.O.U. Maggiore della Carita di Novara
Novara, Italy Recruiting -
Masarykova nemocnice v Usti nad Labem
Ústí nad Labem, Czechia Not yet recruiting -
Semmelweis University
Budapest, Hungary Not yet recruiting -
University of Szeged
Szeged, Hungary Not yet recruiting -
Ospedale Di Summa - Perrino
Brindisi, Italy Not yet recruiting -
Niguarda hospital
Milan, Italy Not yet recruiting
Show 6 more locations
-
Ospedale di Piove di Sacco
Piove di Sacco, Italy Not yet recruiting -
Fondazione Policlinico Universitario "Agostino Gemelli" Università Cattolica del Sacro Cuore
Roma, Italy Not yet recruiting -
SS Annunziata Taranto
Taranto, Italy Not yet recruiting -
Unidade local de Saúde de Coimbra, EPE - Centro Hospitalar Universitario de Coimbra
Coimbra, Portugal Not yet recruiting -
Hospital Universitario 12 de Octubre
Madrid, Spain Not yet recruiting -
Hospital Universitario La Fe
Valencia, Spain Not yet recruiting
Study contacts
- Study coordinator: Martina Del Maestro
- Email: CLS-CSP-STREAM@biotronik.com
- Phone: +393426529214
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
This study tests whether focal cryoablation can treat vagally driven slow heart rhythms as well as traditional radiofrequency ablation in adults with bradycardia or related syncope.
-
Remote ECG monitoring after TAVI
This compares continuous 30-day remote ECG monitoring to standard short-term monitoring for adults after TAVI to see if it detects rhythm problems earlier.
-
Conduction system pacing vs. traditional pacing in adults with atrioventricular block
This study tests whether stimulating the heart’s conduction system can reduce heart failure events for adults needing pacemakers due to AV block.
-
Comparing two pacemaker pacing methods for AV block
This trial tests whether conduction system (left bundle branch area) pacing or standard right ventricular pacing works better for people with atrioventricular block who need a permanent pacemaker.
-
Left bundle branch pacing versus right ventricular pacing to reduce device‑detected fast atrial episodes in people with preserved ejection fraction
This trial will test whether left bundle branch pacing (LBBP) reduces the total time people with preserved ejection fraction spend in device‑detected fast atrial episodes compared with standard right ventricular pacing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.